Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 2012-2014, 2007; 10.1373/clinchem.2007.091165
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 091165.Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garbett, N. C.
Right arrow Articles by Chaires, J. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Garbett, N. C.
Right arrow Articles by Chaires, J. B.
Related Collections
Right arrow Oak Ridge Conference
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2007;53:2012-2014.)
© 2007 American Association for Clinical Chemistry, Inc.


Abstracts of Oak Ridge Posters

Interrogation of the Plasma Proteome with Differential Scanning Calorimetry

Nichola C. Garbett1, James J. Miller2,a, A. Bennett Jenson1, Donald M. Miller1 and Jonathan B. Chaires1

(1 James Graham Brown Cancer Center and 2 Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY;

aaddress correspondence to this author at: Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY 40292; fax 502-852-1771, e-mail jmiller@louisville.edu)

The first 300 words of the full text of this article appear below.

Human plasma is a complex fluid that contains more than 3000 individual proteins and peptides in quantities ranging from nanograms to tens of grams per liter (1)(2). The plasma proteome and peptidome(3) hold great promise for disease diagnosis and therapeutic monitoring(4)(5). In recent years proteomics has focused primarily on analysis of low-abundance proteins by use of high-resolution methods such as 2-dimensional electrophoresis(6) and mass spectrometry(7). These methods have identified changes in the composition of low-abundance proteins and peptides in plasma that correlate with particular diseases. Typically no single protein emerges from such analyses as a wholly reliable biomarker. Instead changes in the pattern of proteins and peptides often serve as the best diagnostic indicator for a particular disease. In addition, many components of the peptidome were found to be complexed with more abundant serum proteins, especially human serum albumin and immunoglobulins. These findings led to the concept of the "interactome"(8).

Currently, the routine clinical laboratory procedures that are used to assess major components of the proteome include protein electrophoresis (PE) and immunofixation electrophoresis. Modern differential scanning calorimetry (DSC) provides a direct means for detecting what is perhaps the most fundamental property of biochemical reactions, heat changes, and can reliably measure heat changes of 0.1 µcal. In a typical DSC experiment, an aqueous solution of protein is heated at a constant rate in the sample cell alongside an identical reference cell that contains only the solvent (buffer). Thermal balance between the sample and reference cells is maintained by electrically powered feedback heaters. Any chemical process in the sample cell that absorbs or releases heat results in a thermal imbalance. The power applied by the feedback heaters provides a direct measure of heat capacity changes accompanying . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.